PATENT CLAIM ANALYSIS

Application Number: 16050472
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "002300"]

Abstract:
The present disclosure relates to novel cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide, and methods to make and use the novel cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide.

Claim (Index 4):
The compound of  claim 1 , wherein R 1  or R 1 \u2014X represents an antibiotic moiety, wherein the antibiotic moiety is of an antibiotics selected from the group consisting of Gentamicin, Streptomycin, Kanamycin, Fradiomyctn, Paromomycin, Tobramycin, Netilmicin, Amikacin, Neomycin, Ribostamycin, Dibekacin, Sisomicin, Isepamicin, Bekanamycin, Astromicin, Plazomicin, Vancomycin, Linezolid, Erythromycin, Eperezolid, and any derivative thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.61905
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13122156', '14713857', '15107531', '11662806', '14117742']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7887674424196316
- 35 USC 102 Novelty (BERT): 0.4917870871249558
- Combined Prediction Score: 0.7590694068901641
- Mean Citation Score: 195.92352
- Max Citation Score: 203.26004
- Similarity Product: 137.71121112411737

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test